[18-20], the blood levels of LMet in a 67year-old female with late-stage ovarian cancer decreased by 50% within 4 h after taking 250 units of orMETase
For GLP-1 patients with potentially suppressed fibroblast support from ADSCs, this provides direct receptor-level stimulation that operates through a different pathway than the GLP-1 mechanism
Barrington P, Chien JY, Tibaldi F, Showalter HD, Schneck K, Ellis B
We will definitely link that article you were referencing
The decision requires collaboration between your weight loss provider and gastroenterology team, with baseline assessment of disease severity, current medications (biologics, immunosuppressants, or corticosteroids), and recent imaging or endoscopy findings